Edoxaban Impurity 160 | CAS 1053656-51-1 - Request Quote
Edoxaban Impurity 160
| SZ CAT No: | SZ-E041200 |
| CAS No | 1053656-51-1 |
| Mol.F. | C14H20N2O4S |
| Mol.Wt. | 312.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 160 is chemically 5-(Tert-butyl) 2-ethyl 6,7-dihydrothiazolo[5,4-c]pyridine-2,5(4H)-dicarboxylate. Edoxaban Impurity 160 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 160 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1053656-51-1
Purchase 1053656-51-1
Order 1053656-51-1
Enquire 1053656-51-1
price of 1053656-51-1
1053656-51-1 Supplier
1053656-51-1 Manufacturer
1053656-51-1 Exporter
buy high quality Edoxaban Impurity 160
Purchase Edoxaban Impurity 160
Edoxaban Impurity 160 suppliers
Edoxaban Impurity 160 manufacturers
Edoxaban Impurity 160 price
Order Edoxaban Impurity 160
Enquire Edoxaban Impurity 160
Edoxaban Impurity 160 cost
Edoxaban Impurity 160 Supplier
Edoxaban Impurity 160 Distributor
Edoxaban Impurity 160 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 160 for ANDA Filing
Edoxaban Impurity 160 for Forced Degradation Studies
Edoxaban Impurity 160 Identification Standards
Edoxaban Impurity 160 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.